
Granules India Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Prazosin Hydrochloride Capsules".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Prazosin Hydrochloride Capsules".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India